Clinical Trials Logo

Menopause Related Conditions clinical trials

View clinical trials related to Menopause Related Conditions.

Filter by:

NCT ID: NCT03178695 Completed - Infertility Clinical Trials

Inovium Ovarian Rejuvenation Trials

Start date: June 1, 2017
Phase: Phase 1
Study type: Interventional

The Inovium Ovarian Rejuvenation Treatment is a PRP-based autologous treatment used in combination with a stimulated IVF sequence and Pre-Implantation Genetic Screening to treat infertility in women experiencing menopause, perimenopause, and premature ovarian failure.

NCT ID: NCT03150407 Completed - Clinical trials for Postmenopausal Symptoms

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

This investigation is designed to demonstrate the safety and efficacy of the VR101 lubricating intravaginal ring (IVR) in treating the symptoms of vaginal dryness. In the proposed investigation, participants will use VR101 devices and sham control rings in a crossover study design. All participants who successfully complete the crossover study will be given the option to continue using VR101 for a total of 13 consecutive weeks to evaluate the long-term safety of the new device.

NCT ID: NCT03082040 Completed - Menopause Clinical Trials

A Home-based Breathing Training on Menopausal Symptoms

Start date: October 26, 2016
Phase: N/A
Study type: Interventional

This is a prospective, triple-blinded and randomized controlled trial examining the effects of a home-based breathing training assisted with biofeedback on menopausal symptoms and autonomic functions among community menopausal women. We also examines whether the changes in autonomic functions would be mediators between slow breathing and menopausal symptoms. This study will include menopausal women, aged from 45 to 64, who experienced menopausal symptoms. Participants will be randomly assigned to either an intervention group (n = 80) or a waiting-list control group (n = 80). The intervention group will undergo the home-based breathing training 20 minutes twice daily and participants in the control condition will participate the same breathing training after a four-week waiting list period. The primary outcome measures are menopausal symptoms measured by symptom diaries of menopausal symptoms and the Greene Climacteric Scale (GCS). Secondary outcome measures are autonomic functions expressed by blood pressure (BP), heart rate (HR) and heart rate variability (HRV). Measurements will be taken at baseline, week 4, and week 8.

NCT ID: NCT03043690 Completed - Clinical trials for Menopause Related Conditions

A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms

Start date: February 11, 2017
Phase: N/A
Study type: Observational

This study is a pooled statistical analysis of the data from 2 studies concerning efficacy of ammonium-succinate based dietary supplement. In both studies group 1 took the ammonium-succinate based dietary supplement and the group 2 took placebo.